| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 5.632 | 0 | 0 | 0 |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 6.517 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | -885 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | -885 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Raimimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 82 | 81 | 79 | 78 | 76 | 75 | 73 | 74 | 73 | 73 |
| Current Assets | 7.390 | 7.315 | 7.191 | 7.059 | 6.922 | 6.667 | 2 | 2 | 2 | 2 |
| Inventories | 3.629 | 3.590 | 3.529 | 3.464 | 3.397 | 3.333 | 0 | 0 | 0 | 0 |
| Receivables | 3.627 | 3.592 | 3.531 | 3.466 | 3.399 | 3.335 | 2 | 2 | 2 | 2 |
| Cash | 135 | 134 | 131 | 129 | 126 | 0 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -5.771 | -5.712 | -5.616 | -5.513 | -5.406 | -4.013 | -4.810 | -4.824 | -4.810 | -4.783 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 13.243 | 13.108 | 12.886 | 12.650 | 12.405 | 10.756 | 4.885 | 4.900 | 4.885 | 4.858 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Raimimed S.r.l.